Small clinical trial finds two forms of immunotherapy may be better than one for treating metastatic melanoma
June 6, 2016
| By Rachel Tompa / Fred Hutch News Service
Matthew Flood, a retired EMT from the Tacoma Fire Department, is one of 10 patients with metastatic melanoma treated with an experimental combination of immunotherapies between 2011 and 2013. In a study published today in the Journal of Clinical Oncology, the research team described the small clinical trial and how the patients have fared in the years following their treatment. Flood is now in complete remission five years after receiving the combo immunotherapy.
Aided by six Hutchinson Center 'doctor partners,' local grade schoolers explore possible cancer cures, visit campus
May 29, 2012
| By Colleen Steelquist
Budding sixth-grade scientists from Snohomish's Dutch Hill Elementary School recently spent the day on the Fred Hutchinson Cancer Research Center campus, the culmination of a yearlong exploratory partnership with Center researchers.
Cassian Yee study shows progress in using patients' own tumor-fighting cells to knock back late-stage skin cancer
March 5, 2012
| By Dean Forbes
A small, early-phase clinical trial, led by Dr. Cassian Yee of the Hutchinson Center's Clinical Research Division, to test the effectiveness of treating patients with advanced melanoma using billions of clones of their own tumor-fighting cells combined with a specific type of chemotherapy has shown that the approach has promise. One patient of the 11 experienced a long-term, complete remission that has lasted more than three years, and in four others with progressive disease, the melanoma temporarily stopped growing. The results of the study appear in the March 5 early edition of the Proceedings of the National Academy of Sciences.
Amanda Claire McIntyre will use the national award from the Joanna M. Nicolay Melanoma Foundation to complete her doctorate in the UW’s Molecular & Cellular Biology program
April 18, 2011
| By Dean Forbes
Amanda Claire McIntyre, a University of Washington graduate student in the Fred Hutchinson Cancer Research Center's Yee Lab, was one of seven graduate students nationally chosen to receive a competitive $10,000 research scholar award by the Joanna M. Nicolay Melanoma Foundation.
Collaborative achievements in T-cell immunotherapies cited
Oct. 11, 2010
Two dozen researchers from the Fred Hutchinson/University of Washington Cancer Consortium received first-ever Team Science awards from the International Society for Biological Therapy of Cancer on Oct. 3 at the organization’s 25th annual meeting in Washington, D.C.
Fred Hutch is proud to be an Equal Opportunity and VEVRAA Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. Read the EEO is the Law poster here.